Unique ID issued by UMIN | UMIN000039324 |
---|---|
Receipt number | R000044842 |
Scientific Title | Studies on the inhibitory effect of DHA / EPA supplementation on immediate-type food allergic reactions |
Date of disclosure of the study information | 2020/01/30 |
Last modified on | 2020/04/13 13:04:58 |
Studies on the inhibitory effect of DHA / EPA supplementation on immediate-type food allergic reactions
Studies on the inhibitory effect of DHA / EPA supplementation on immediate-type food allergic reactions
Studies on the inhibitory effect of DHA / EPA supplementation on immediate-type food allergic reactions
Studies on the inhibitory effect of DHA / EPA supplementation on immediate-type food allergic reactions
Japan |
food allergy
Clinical immunology | Pediatrics |
Others
NO
To verify the effects of supplementing DHA / EPA on plasma fatty acid to reduce immediate food allergic reaction.
Efficacy
Exploratory
Pragmatic
Not applicable
Change in ratio of Total score of Anaphylaxis scoring aichi (ASCA) divided by cumulative load protein.
1. Change in plasma total lipid fatty acid fraction: Change in (EPA + DHA) / AA ratio
2. Change in total IgE value
3. Changes in specific IgE levels
4. Changes in intestinal flora analysis
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Food |
Continue to take dairy lactic acid bacteria beverage containing 720 mg DHA and 180 mg EPA once a day for 5 days or more a week.
Taking the test food for 12-15 weeks.
3 | years-old | <= |
10 | years-old | > |
Male and Female
1. Patients who tested positive for OFC in eggs (Boiled egg whites) and were instructed to completely remove them.
2. Patients aged between 3 and younger than 10
3. Patients who tasted a test food and are expected to consume it continuously for three months
4. Patients who can receive the test food once a week
5. Patients who are not allergic to milk
1. Patients who are taking supplements such as DHA containing food or probiotic food continuously.
2. Patients with TS score of 41 or higher induced by initial OFC (Patients for whom the safety of the evaluation OFC is not guaranteed)
3. Patients who have systemic diseases other than allergies
4. Patients who are judged by a physician to be unsuitable
10
1st name | Komei |
Middle name | |
Last name | Ito |
Aichi Children's Health and Medical Center
Department of General Pediatrics and allergy
474-8710
7-426, Morioka-cho, Obu-shi, Aichi, Japan.
0562-43-0500
koumei_itoh@mx.achmc.pref.aichi.jp
1st name | Yukiko |
Middle name | |
Last name | Iwawaki |
Aichi Children's Health and Medical Center
Department of Allergy
474-8710
7-426, Morioka-cho, Obu-shi, Aichi, Japan.
0562-43-0500
allergy-secretary@cd5.so-net.ne.jp
Aichi Children's Health and Medical Center
ORTHOMEDICO Inc.
Profit organization
Nobel CO,.LTD.
Takara Clinic Certified Review Board
9F Taisei Building, 2-3-2, Higashi-gotanda, Shinagawa-ku, Tokyo, Japan.
03-5793-3623
CRB@takara-clinic.com
YES
jRCTs031190192
Japan Registry of Clinical Trials
あいち小児保健医療総合センター (愛知県)
Aichi Children's Health and Medical Center (Aichi, Japan)
2020 | Year | 01 | Month | 30 | Day |
Unpublished
Enrolling by invitation
2019 | Year | 12 | Month | 03 | Day |
2019 | Year | 12 | Month | 03 | Day |
2020 | Year | 02 | Month | 28 | Day |
2021 | Year | 03 | Month | 31 | Day |
2020 | Year | 01 | Month | 30 | Day |
2020 | Year | 04 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044842
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |